Table 3.

25 Differential lipid metabolites among TB0, TB2, TB6, and HC

			Ratios
No.	Differential compounds	Ion mode	TB0/HC	TB2/HC	TB6/HC	TB0/TB2	TB0/TB6	TB2/TB6
1	LPA (0:0/16:0)	N	3.99	2.16	1.33	1.85	3	1.62
2	LPA (0:0/18:0)	N	5.49	2.99	1.82	1.84	3.02	1.64
3	PC (20:3/18:1)	N	1.39	1.79	1.36	0.78	1.03	1.32
4	PC (16:0/20:5)	N	0.92	0.6	0.74	1.53	1.24	0.81
5	PC (18:2/20:3)	N	1.13	1.5	1.18	0.75	0.96	1.28
6	Myristoyl-carnitine	P	0.77	1.07	0.89	0.72	0.87	1.21
7	Dodecenoyl-carnitine	P	0.66	0.97	0.79	0.68	0.84	1.24
8	Tetradecenoyl-carnitine	P	0.77	1.23	0.93	0.63	0.83	1.33
9	Palmitodileoyl-carnitine	P	0.68	1.18	0.87	0.57	0.78	1.36
10	Cer (d18:1/20:0)	P	1.36	1.84	2.31	0.74	0.59	0.8
11	Cer (d18:1/24:0)	P	0.79	1.03	1.27	0.77	0.62	0.81
12	CerP (d18:1/20:3)	P	0.76	0.97	1.23	0.78	0.62	0.79
13	LPE (0:0/22:0)	P	0.69	0.88	1.09	0.78	0.63	0.81
14	PE (P-20:2/22:3)	P	0.67	0.54	0.7	1.24	0.96	0.77
15	TG (18:1/18:3/20:0)	P	1.09	1.31	0.95	0.83	1.15	1.38
16	TG (16:1/20:1/20:2)	P	1.05	1.34	1.03	0.78	1.02	1.31
17	TG (18:2/18:2/20:0)	P	1	1.27	0.96	0.78	1.04	1.32
18	TG (14:1/14:1/22:3)	P	0.86	1.12	1.34	0.77	0.64	0.84
19	TG (18:2/18:3/20:0)	P	0.98	1.36	0.97	0.72	1.02	1.41
20	TG (18:0/18:3/20:2)	P	1.06	1.37	1.03	0.77	1.03	1.34
21	TG (18:1/18:3/20:1)	P	0.97	1.36	1.07	0.71	0.91	1.28
22	TG (16:0/16:0/22:6)	P	0.77	0.36	0.66	2.17	1.17	0.54
23	TG (16:0/16:1/22:5)	P	1.08	0.64	0.85	1.69	1.27	0.75
24	TG (14:0/20:2/20:5)	P	0.9	0.53	0.83	1.69	1.08	0.64
25	TG (16:0/16:1/22:6)	P	0.94	0.53	0.85	1.77	1.1	0.62

P positive, N negative